Literature DB >> 689741

Cyclophosphamide effects on murine cryptococcosis.

J R Graybill, L Mitchell.   

Abstract

BALB/c mice were given cyclophosphamide and challenged with Cryptococcus neoformans. Delayed-type hypersensitivity was transiently depressed, and survival was either unaffected or shortened by cyclophosphamide.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 689741      PMCID： PMC422048          DOI： 10.1128/iai.21.2.674-677.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  9 in total

1.  Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse.

Authors:  J A Kerckhaert; F M Hofhuis; J M Willers
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

2.  Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.

Authors:  A Schwartz; S Orbach-Arbouys; R K Gershon
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

3.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations.

Authors:  J E Balow; D L Hurley; A S Fauci
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

5.  Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice.

Authors:  N A Sher; S D Chaparas; L E Greenberg; S Bernard
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

6.  Cyclophosphamide pretreatment and protection against malaria.

Authors:  J F Finerty; E P Krehl
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

7.  Host defense in cryptococcosis. I. An in vivo model for evaluating immune response.

Authors:  J R Graybill; R L Taylor
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

8.  Effect of cyclophosphamide on Histoplasma capsulatum infections in mice.

Authors:  G C Cozad; T J Lindsey
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

9.  Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307
  9 in total
  11 in total

1.  Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Authors:  Maged Muhammed; Marta Feldmesser; Lisa F Shubitz; Michail S Lionakis; Anita Sil; Yan Wang; Justin Glavis-Bloom; Russell E Lewis; John N Galgiani; Arturo Casadevall; Dimitrios P Kontoyiannis; Eleftherios Mylonakis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

2.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.

Authors:  M R Hidore; J W Murphy
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Authors:  M S Ascher; P B Jahrling; D G Harrington; R A Kishimoto; V G McGann
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

5.  Experimental cryptococcosis in normal and B-cell-deficient mice.

Authors:  D P Monga; R Kumar; L N Mohapatra; A N Malaviya
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice.

Authors:  F Bistoni; M Baccarini; E Blasi; P Marconi; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

7.  Effect of cyclophosphamide on rats experimentally infected with Cryptococcus neoformans.

Authors:  C M Riera; D T Masih; H Rubinstein; R Nobile; V R Vega
Journal:  Mycopathologia       Date:  1984-12-30       Impact factor: 2.574

8.  Immune responses elicited by vaccinations with Candida albicans ribosomes in cyclophosphamide treated animals.

Authors:  E Segal; H Sandovsky-Losica; S Nussbaum
Journal:  Mycopathologia       Date:  1985-02       Impact factor: 2.574

9.  Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.

Authors:  M Baccarini; F Bistoni; P Puccetti; E Garaci
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.

Authors:  S A Moser; F L Lyon; J E Domer; J E Williams
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.